Event Picture Display NovaLead Pharma announces completion of trials of GALNOBAX Album
Fotocorp

NovaLead Pharma announces completion of trials of GALNOBAX Album

Date: 03-11-2015 | Total Images: 5

Supreet Deshpande, MD & President, US subsidiary- NovaLead Pharma Inc addresses during the announcement of successful completion of global phase I /II clinical trial for Galnobax®: a topical gel for treatment of Diabetic Foot Ulcer (DFU) in Mumbai on Tuesday, 03 November 2015.
Supreet Deshpande, MD & President, US subsidiary- NovaLead Pharma Inc addresses during the announcement of successful completion of global phase I /II clinical trial for Galnobax®: a topical gel for treatment of Diabetic Foot Ulcer (DFU) in Mumbai on Tuesday, 03 November 2015.
Uploaded: 03-11-2015 16:15:00
Supreet Deshpande, MD & President, US subsidiary- NovaLead Pharma Inc addresses during the announcement of successful completion of global phase I /II clinical trial for Galnobax®: a topical gel for treatment of Diabetic Foot Ulcer (DFU) in Mumbai on Tuesday, 03 November 2015.
Supreet Deshpande, MD & President, US subsidiary- NovaLead Pharma Inc addresses during the announcement of successful completion of global phase I /II clinical trial for Galnobax®: a topical gel for treatment of Diabetic Foot Ulcer (DFU) in Mumbai on Tuesday, 03 November 2015.
Uploaded: 03-11-2015 16:15:00
Dr PKS Sharma, Head (Technical Discovery & Product Development), BIRAC, Homi Khusrokhan, Director, ICICI Bank Limited, Prakash Bhoopatkar, Dr Manisha Deshmukh, General Physician, Sanjay M Vaidya, MBBS & MS & Supreet Deshpande, MD & President, US subsidiary- NovaLead Pharma Inc addresses during the announcement of successful completion of global phase I /II clinical trial for Galnobax®: a topical gel for treatment of Diabetic Foot Ulcer (DFU) in Mumbai on Tuesday, 03 November 2015.
Dr PKS Sharma, Head (Technical Discovery & Product Development), BIRAC, Homi Khusrokhan, Director, ICICI Bank Limited, Prakash Bhoopatkar, Dr Manisha Deshmukh, General Physician, Sanjay M Vaidya, MBBS & MS & Supreet Deshpande, MD & President, US subsidiary- NovaLead Pharma Inc addresses during the announcement of successful completion of global phase I /II clinical trial for Galnobax®: a topical gel for treatment of Diabetic Foot Ulcer (DFU) in Mumbai on Tuesday, 03 November 2015.
Uploaded: 03-11-2015 16:15:00
Dr PKS Sharma, Head (Technical Discovery & Product Development), BIRAC, Homi Khusrokhan, Director, ICICI Bank Limited, Prakash Bhoopatkar, Dr Manisha Deshmukh, General Physician, Sanjay M Vaidya, MBBS & MS & Supreet Deshpande, MD & President, US subsidiary- NovaLead Pharma Inc poses during the announcement of successful completion of global phase I /II clinical trial for Galnobax®: a topical gel for treatment of Diabetic Foot Ulcer (DFU) in Mumbai on Tuesday, 03 November 2015.
Dr PKS Sharma, Head (Technical Discovery & Product Development), BIRAC, Homi Khusrokhan, Director, ICICI Bank Limited, Prakash Bhoopatkar, Dr Manisha Deshmukh, General Physician, Sanjay M Vaidya, MBBS & MS & Supreet Deshpande, MD & President, US subsidiary- NovaLead Pharma Inc poses during the announcement of successful completion of global phase I /II clinical trial for Galnobax®: a topical gel for treatment of Diabetic Foot Ulcer (DFU) in Mumbai on Tuesday, 03 November 2015.
Uploaded: 03-11-2015 16:14:00
Dr PKS Sharma, Head (Technical Discovery & Product Development), BIRAC, Homi Khusrokhan, Director, ICICI Bank Limited, Prakash Bhoopatkar, Dr Manisha Deshmukh, General Physician, Sanjay M Vaidya, MBBS & MS & Supreet Deshpande, MD & President, US subsidiary- NovaLead Pharma Inc poses during the announcement of successful completion of global phase I /II clinical trial for Galnobax®: a topical gel for treatment of Diabetic Foot Ulcer (DFU) in Mumbai on Tuesday, 03 November 2015.
Dr PKS Sharma, Head (Technical Discovery & Product Development), BIRAC, Homi Khusrokhan, Director, ICICI Bank Limited, Prakash Bhoopatkar, Dr Manisha Deshmukh, General Physician, Sanjay M Vaidya, MBBS & MS & Supreet Deshpande, MD & President, US subsidiary- NovaLead Pharma Inc poses during the announcement of successful completion of global phase I /II clinical trial for Galnobax®: a topical gel for treatment of Diabetic Foot Ulcer (DFU) in Mumbai on Tuesday, 03 November 2015.
Uploaded: 03-11-2015 16:14:00